Human Metabolome Technologies, Inc. (6090.T)

JPY 672.0

(-0.44%)

Revenue Summary of Human Metabolome Technologies, Inc.

  • Human Metabolome Technologies, Inc.'s latest annual revenue in 2023 was 1.34 Billion JPY , up 3.57% from previous year.
  • Human Metabolome Technologies, Inc.'s latest quarterly revenue in 2023 FY was 1.34 Billion JPY , up 3.57% from previous quarter.
  • Human Metabolome Technologies, Inc. reported a annual revenue of 1.29 Billion JPY in annual revenue 2022, up 6.21% from previous year.
  • Human Metabolome Technologies, Inc. reported a annual revenue of 1.22 Billion JPY in annual revenue 2021, up 8.83% from previous year.
  • Human Metabolome Technologies, Inc. reported a quarterly revenue of 1.34 Billion JPY for 2023 FY, up 3.57% from previous quarter.
  • Human Metabolome Technologies, Inc. reported a quarterly revenue of 235.24 Million JPY for 2023 Q1, up 5.04% from previous quarter.

Annual Revenue Chart of Human Metabolome Technologies, Inc. (2023 - 2019)

Historical Annual Revenue of Human Metabolome Technologies, Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 1.34 Billion JPY 3.57%
2022 1.29 Billion JPY 6.21%
2021 1.22 Billion JPY 8.83%
2020 1.12 Billion JPY 0.5%
2019 1.11 Billion JPY 0.0%

Peer Revenue Comparison of Human Metabolome Technologies, Inc.

Name Revenue Revenue Difference
Shin Nippon Biomedical Laboratories, Ltd. 26.45 Billion JPY 94.912%
DNA Chip Research Inc. 490.46 Million JPY -174.368%
Cosmo Bio Company,Limited 9.34 Billion JPY 85.592%
H.U. Group Holdings, Inc. 236.95 Billion JPY 99.432%
FALCO HOLDINGS Co., Ltd. 43 Billion JPY 96.871%
BML, Inc. 137.96 Billion JPY 99.025%
Precision System Science Co., Ltd. 3.97 Billion JPY 66.189%